Bottom line
Is CSD a good fund? The bottom line
CSD is an index large blend ETF from Invesco.
Its expense ratio is 0.65% — about $65 a year on every $10,000 invested, cheaper than 67% of large blend funds we track.
It returned +21.4% over one year, +13.0% a year over five years, +10.9% a year over ten (as of Dec 31, 2025, per its prospectus).
With $226 million in net assets and 31 holdings, its largest position is GE HealthCare Technologies Inc. (8.2%) and the top 10 make up 62.6% of the portfolio.
What stands out
- 5-year return beat 75% of category peers
What to watch
- Concentrated: top 10 holdings are 62.6% of assets
- High turnover (117% a year) can mean more taxable distributions
Updated Nov 19, 2026
What CSD invests in
The Invesco S&P Spin-Off ETF (the Fund) seeks to track the investment results (before fees and expenses) of the S&P U.S. Spin-Off Index (the Underlying Index).
The Fund is an index fund that seeks to track the investment results of the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (S&P DJI or the Index Provider) compiles and maintains the Underlying Index, which is designed to measure the performance of U.S. companies that have been spun off from a parent company within the past four years. The Underlying Index is comprised of equity securities of U.S. companies in the S&P U.S. BMI, a country sub-index of the S&P Global BMI, that have been spun off and have a float-adjusted market capitalization of at least $1 billion at the time they are added to the Underlying Index. The Index Provider defines a spin-off company as any company resulting from one of the following events: ? Spin-off. A spin-off occurs when a company divests a subsidiary or division to create a new, independent…
From the fund's prospectus (filed Aug 27, 2026).
CSD performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| CSD | +21.4% | +13.0% | +10.9% |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What CSD costs
On a $10,000 investment, CSD's 0.65% expense ratio costs about $65 a year. The prospectus estimates $821 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
CSD top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | GE HealthCare Technologies Inc. | 8.19% |
| 2 | Veralto Corp. | 8.00% |
| 3 | GE Vernova Inc. | 7.20% |
| 4 | Qnity Electronics, Inc. | 7.19% |
| 5 | Honeywell Aerospace Inc. | 7.18% |
| 6 | Sandisk Corp. | 5.48% |
| 7 | Solventum Corp. | 5.31% |
| 8 | Invesco Private Prime Fund | 4.76% |
| 9 | Crane Co. | 4.66% |
| 10 | Solstice Advanced Materials Inc. | 4.61% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 62.6% of the fund. See all top 25 holdings and asset mix →